Mary Whooley. MD: Tips for the PCORI Application Process

•Transferir como PPTX, PDF•

1 gostou•1,185 visualizações

Panelist Mary Whooley, MD, is a successful PCORI applicant and CER researcher. She presents Tips for the PCORI Application Process.

Saúde e medicina

Tips for the PCORI Application Process

Mary Whooley, MD, FACP, FAHA, FACC

San Francisco VA Medical Center
Professor of Medicine, Epidemiology and Biostatistics
University of California, San Francisco

January 16, 2014

PCORI Due Dates (4 cycles/year)*
Cycle

LOI

Proposal

Notification

Funding

Fall

Sept

Nov

March

July

Winter

Dec

Feb

June

Oct

Spring

March

May

Sept

Jan

June

August

Dec

April

Summer

*Dates are currently being revised:
http://www.pcori.org/funding-opportunities/funding-center/

Standing PCORI Funding Announcements (PFAs)
PFA (Max direct costs over 3 years)

Total funds
available
per cycle

Approx. #
proposals
funded per cycle

Assessment of Prevention, Diagnosis
and Treatment Options (1.5M)

32 million

16

Improving Healthcare Systems (1.5M)

16 million

8

Communication and Dissemination
Research (1.5M)

8 million

4

Addressing Disparities (1.5M)

8 million

4

Methods for Conducting PatientCentered Outcomes Research (750K)

8 million

8

http://www.pcori.org/funding-opportunities/funding-center/

PCORI Methodology Report, updated 11/18/13

• http://www.pcori.org/assets/PCORI-Methodology-Standards1.pdf

• http://www.pcori.org/assets/2013/11/PCORI-Methodology-Report.pdf
(see summary of methodology standards on p.11-12)

Proposal – Most Important Sections
A. Research Strategy
•
•
•
•
•
•

Criterion 1: Impact of the condition on health of individuals and
populations
Criterion 2: Potential for improving care and outcomes
Criterion 3: Effects on healthcare delivery
Criterion 4: Patient-centeredness
Criterion 5: Rigorous research methods
Criterion 6: Inclusiveness of different populations

B. Dissemination and Implementation Assessment
C. Patient and Stakeholder Engagement Plan
D. Letters of Support

Mais conteúdo relacionado

Mais procurados

Virtual tumor boards for remote patient oncology

Jim Smurro

About CURE OM - 2019 CURE OM Symposium

Melanoma Research Foundation

Coursera rprog 2015

Sanjay Bhatikar Ph.D., PMP

Targeted translational RFA for Rare tumor subtypes and exceptional responders...

Wafik El-Deiry, MD PhD FACP

Clinical Research Office Newsletter volume 1 Issue 1

Dr. Roberto Torres

@ 101 power point owen walker

drrcpawv1

Alert 2014-progress-lemke

INSPIRE_Network

Coursera getdata 2014

Matan Zittoun

Certificate reproducible research 2015

Isabelle Valette

Baylor University Medical Center Named a Best Hospital by US News

Bruce Selkirk

Coursera appliedregression 2016

Shantanu Mukherjee

Coursera rprog 2015

Atul Khot

Coursera rprog 2015

KrishnaMohan Avancha **LION**

DataStart Final

Samia F. Ansari

From RAE to REF

David Clay

RProgramming

Laurent Debacker

This third webinar in the series of Adverse Outcome Pathways (AOPs) was organised on Thursday 30 January 2020. It focused on the core information and telecommunication technologies applications that were built to support AOP development, management and dissemination. Tools and technical tips to facilitate scientific knowledge assembling and evaluations were also presented. The AOP framework implements a collaborative and innovative approach for collecting mechanistic knowledge from various sources that can eventually support chemical safety assessment. Clemens Wittwehr from the European Commission Joint Research Centre provided an introduction on AOP-KB.

Adverse Outcome Pathways Knowledge Base (AOP-KB) Introduction - Clemens Wittw...

OECD Environment

FactSheet-GMaPContact Revised 9-23-2016

GMaP Region 2

Harm reduction perspective on HHS Viral Hepatitis Action Plan

Harm Reduction Coalition

CHED Journal Accreditation Service (JAS) by Atty. Julito D. Vitriolo

Philippine E-Journals (PEJ)

Mais procurados (20)

Virtual tumor boards for remote patient oncology

About CURE OM - 2019 CURE OM Symposium

Coursera rprog 2015

Targeted translational RFA for Rare tumor subtypes and exceptional responders...

Clinical Research Office Newsletter volume 1 Issue 1

@ 101 power point owen walker

Alert 2014-progress-lemke

Coursera getdata 2014

Certificate reproducible research 2015

Baylor University Medical Center Named a Best Hospital by US News

Coursera appliedregression 2016

Coursera rprog 2015

DataStart Final

From RAE to REF

RProgramming

Adverse Outcome Pathways Knowledge Base (AOP-KB) Introduction - Clemens Wittw...

FactSheet-GMaPContact Revised 9-23-2016

Harm reduction perspective on HHS Viral Hepatitis Action Plan

CHED Journal Accreditation Service (JAS) by Atty. Julito D. Vitriolo

Semelhante a Mary Whooley. MD: Tips for the PCORI Application Process

Elite research network 2011

Elite Research Network

Becker, Lynne resume Mar 2016

Lynne Becker

Becker, lynne resume mar2016

Lynne Becker

FLASCO: WHY YOU SHOULD BELONG & LEGISLATIVE UPDATE

flasco_org

Open access to clinical trials through prospective clinical trials registries

BioMedCentral

Cavity Free @ 3 CityMatch Presentation

Jefferson County Public Health

Patient Navigation Across the Continuum

Academy of Oncology Nurse Navigators, Inc.

Tga presentation National Medicines Symposium 19 may 2016

TGA Australia

Supporting the use of evidence by policy makers in LMIC: the evidence-informe...

cmaverga

Running head: MAYO CLINIC 1 Mayo Clinic 2 Mayo Clinic Kurtis Gray HA499 Kaplan University 16 February 2016 Mayo clinical is a not-for-profit organization based in Rochester, Minnesota. It is one of the largest medical practice and medical research group in the world and has employed more than 3,800 physicians and over 50,000 scientists allied to the staff. It is present in the United States metropolitan areas and has the core values of providing patient care practice represented by the central shield. Patient care has been one of the first priorities of this organization and it has been able to offer highly specialized care hence most of the population in this medical facility are referrals from smaller clinics and other hospitals from across the United States (Ludwig, Viggiano, Mcgill & Oh, 1980). The rationale behind the selection of this organization is that, this clinic has greatly contributed to understanding various disease processes and has been able to provide best clinical practices to patients. It has also helped with the establishment of current residency education system in the institution. It has developed more innovations to help researchers to actually study the interactions between human health and the indoor spaces. Most researchers in this health institution have actually improved patient care hence translating discoveries into therapies which have exponentially improved the lives of individuals in the area (Fontana, Sanderson, Taylor, Woolner, Miller, Muhm & Uhlenhopp, 1984). Mayo clinic has outlined its mission to inspire and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research. The primary value of this clinic is that the patient comes first. The management of this clinic has also been able to enable equal treatment of everyone within the diverse communities including patients, their families with great dignity. It has the compassion to provide the best care to patients with sensitivity and empathy. This hospital has been very successful since it has been able to adhere to the highest standards of professionalism ethics and personal responsibility. It has also enabled the healing process to actually respect the spiritual and physical needs of the patients and also to make sure that the teamwork within the working place creates much excellence in the working environment. Mayo clinic has also been able to deliver the best outcomes through the dedication of all team members in this hospital. Various innovations have also energized Mayo clinic and has greatly contributes to enhancement of people’s lives through creation of ideas as well as various unique talents of all employees in this organization Ludwig (Viggiano, Mcgill, & Oh, 1980). Mayo clinic’s success is based upon training, team work compensation and employees who improve the general health care system of their clients. Putting patient’s interest first is one ...

Running head MAYO CLINIC1Mayo Clinic2.docx

cowinhelen

REG PCORI Grant Planning Meeting 26/09/15

Zoe Mitchell

Board of Governors Special TeleconferenceWebinar on Uterine Fibroids and Asth...

Patient-Centered Outcomes Research Institute

Special Board of Governors Teleconference/Webinar

Patient-Centered Outcomes Research Institute

Zafar CV 0216

Nadeem Zafar

Research Support Community Day 'Research Impact' 8th February 2016

SusanMRob

CTSI Clinical Research Services at UCSF: Mission, Application Process, Contacts

CTSI at UCSF

Cadth 2015 d7 presentation 2015 14 apr15

CADTH Symposium

Colorado Clinical & Translational Science Award

guest041fdb

NIH Research grants (R series) are an important funding mechanism for independent investigators as these awards offer the opportunity to head up major research projects. In this presentation, Dr. Ian de Boer will leverage his experience from winning six different R awards to provide R series grant writing strategies. He explores: which R award is best for you; readiness and qualifications for independent support; formulating focused and solid research strategies; how to avoid common mistakes; tips for early investigators; and NIH expectations and grant requirements.

Successful Grant Writing Strategies for an R Award

Institute of Translational Health Sciences

Caroline Watkins

NHSNWRD

Semelhante a Mary Whooley. MD: Tips for the PCORI Application Process (20)

Elite research network 2011

Becker, Lynne resume Mar 2016

Becker, lynne resume mar2016

FLASCO: WHY YOU SHOULD BELONG & LEGISLATIVE UPDATE

Open access to clinical trials through prospective clinical trials registries

Cavity Free @ 3 CityMatch Presentation

Patient Navigation Across the Continuum

Tga presentation National Medicines Symposium 19 may 2016

Supporting the use of evidence by policy makers in LMIC: the evidence-informe...

Running head MAYO CLINIC1Mayo Clinic2.docx

REG PCORI Grant Planning Meeting 26/09/15

Board of Governors Special TeleconferenceWebinar on Uterine Fibroids and Asth...

Special Board of Governors Teleconference/Webinar

Zafar CV 0216

Research Support Community Day 'Research Impact' 8th February 2016

CTSI Clinical Research Services at UCSF: Mission, Application Process, Contacts

Cadth 2015 d7 presentation 2015 14 apr15

Colorado Clinical & Translational Science Award

Successful Grant Writing Strategies for an R Award

Caroline Watkins

Mais de CTSI at UCSF

AMIA Joint Summits 2017: Building Research Data Mart from UCSF OMOP Database ...

CTSI at UCSF

CER 2016 Trontell pcori cer presentation 2016 02 02 final

CTSI at UCSF

CER 2016 Srivastava

CTSI at UCSF

CER 2016 Phillips cer symposium pcori 2016 from 012716

CTSI at UCSF

CER 2016 Nguyen ctsi collaborative research

CTSI at UCSF

CER 2016 Hernandez patient engagement

CTSI at UCSF

CER 2016 Dohan EQUIP

CTSI at UCSF

CER 2016 Jacoby stakeholder engagement

CTSI at UCSF

CER 2016 Goldman CTSI CER Resources

CTSI at UCSF

CER 2016 Goldman Intro

CTSI at UCSF

On Sep 17th Catalyst brought a panel of academic and industry thought leaders for a lively discussion on the issue of data reproducibility in academic research. Moderated by Cathy Tralau-Stewart, head of the Therapeutics track of the Catalyst Awards, the panel explored causes and potential solutions for a problem that has been receiving national attention in both scientific and popular media. Panelists included Keith Yamamoto, Vice Chancellor for Research at UCSF; Larry Tabak, Principle Deputy Director, NIH; John Ioannidis, Professor of Health Research Policy at Stanford School of Medicine; Elizabeth Iorns, Co-Founder, Science Exchange; Parker B. Antin, Board of Directors President, FASEB; Amanda Halford, MBA, VP of Research, Sigma-Aldrich. http://ctsi.ucsf.edu/news/about-ctsi/data-reproducibility-preclinical-research-and-discovery

Data Reproducibility in Preclinical Discovery, Is It a Real Problem? 09/17/15

CTSI at UCSF

Building Your Professional Network with LinkedIn

CTSI at UCSF

How to Harness the Power of Google Analytics, Email Marketing & Vanity to Inc...

CTSI at UCSF

Poster presented at VIVO 2014 conference: Utilized UCSF Profiles web analytics data to deliver a customized “UCSF Profiles Annual Report” to individual researchers at UCSF, which listed their total annual unique pageviews, broken down by major relevant categories (e.g. pageviews from the UCSF campus, NIH, pharmaceutical companies, foundations, and other universities). Result: Increase in user engagement and edite Profiles pages. UCSF-CTSI Team: Nooshin Latour, MA, Sr. Communications & Marketing Manager and Anirvan Chatterjee, Director of Data Strategy

VIVO 2014: Google Analytics, Email Marketing & Vanity to Increase User Engage...

CTSI at UCSF

UCSF Informatics Day 2014 - Mark Pletcher, "Making EHR Data Useful for the Le...

CTSI at UCSF

UCSF Informatics Day 2014 - Ida Sim, "Informatics Technologies: From a Data-C...

CTSI at UCSF

UCSF Informatics Day 2014 - Keith R. Yamamoto, "Precision Medicine"

CTSI at UCSF

UCSF Informatics Day 2014 - Jocel Dumlao, "REDCap / MyResearch"

CTSI at UCSF

UCSF Informatics Day 2014 - Lindsey Watt Alami, "Study Management throughout ...

CTSI at UCSF

UCSF Informatics Day 2014 - Elizabeth St. Lezin, "Blood Transfusion Research ...

CTSI at UCSF

Mais de CTSI at UCSF (20)